ARRIVENT BIOPHARMA INC

Ticker: AVBP CUSIP: 04272N102 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 450,920 Value ($000) $9,073 Avg Close $20.82 Range $17.00 - $25.82

Q3 2025

Shares 497,601 Value ($000) $9,181 Avg Close $19.65 Range $16.10 - $23.38

Q2 2025

Shares 86,588 Value ($000) $1,885 Avg Close $20.76 Range $15.47 - $25.80

Q1 2025

Shares 202,185 Value ($000) $3,738 Avg Close $24.47 Range $17.84 - $29.71

Q4 2024

Shares 72,693 Value ($000) $1,937 Avg Close $28.71 Range $23.00 - $36.37

Q3 2024

Shares 18,636 Value ($000) $438 Avg Close $22.70 Range $17.21 - $30.99

Q2 2024

Shares 11,985 Value ($000) $222 Avg Close $17.83 Range $14.35 - $21.00

Q1 2024

Shares 9,895 Value ($000) $177 Avg Close $20.17 Range $16.90 - $25.95

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	450,920	$9,073	$20.82	$17.00 - $25.82
Q3 2025	497,601	$9,181	$19.65	$16.10 - $23.38
Q2 2025	86,588	$1,885	$20.76	$15.47 - $25.80
Q1 2025	202,185	$3,738	$24.47	$17.84 - $29.71
Q4 2024	72,693	$1,937	$28.71	$23.00 - $36.37
Q3 2024	18,636	$438	$22.70	$17.21 - $30.99
Q2 2024	11,985	$222	$17.83	$14.35 - $21.00
Q1 2024	9,895	$177	$20.17	$16.90 - $25.95